Morgan Stanley analyst Meta Marshall lowered the firm’s price target on Axon (AXON) to $675 from $713 and keeps an Overweight rating on the shares following Q4 results and an outlook that were “meaningfully better than expectations.” Following the report, the firm increased its estimates for Q1 and out year revenue “meaningfully,” but lowers its target to account for multiples having coming in across software as a whole.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON:
- Axon price target lowered to $690 from $753 at Piper Sandler
- Axon: Strong Q4 Momentum and Upgraded Long-Term Outlook Underpin Buy Rating
- Axon price target lowered to $682 from $702 at Barclays
- Closing Bell Movers: First Solar down 12% on earnings miss
- Axon up 15% to $507.50 after Q4 results beat, strong FY26 revenue guidance